How the tumor environment affects the spread of breast cancer
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
This study is looking at how the area around breast cancer cells helps them spread to other parts of the body, with the goal of finding new ways to treat metastatic breast cancer that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11041058 on NIH RePORTER |
What this research studies
This research investigates how the tumor microenvironment influences the spread of breast cancer to other parts of the body. It focuses on understanding the specific characteristics of cancer cells that allow them to invade and survive in distant organs. By studying the interactions between cancer cells and their surrounding environment, particularly the role of certain proteins and signaling pathways, the research aims to identify potential targets for new therapies. Patients may benefit from insights that could lead to more effective treatments for metastatic breast cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with breast cancer, particularly those with metastatic disease.
Not a fit: Patients with non-breast cancer types or those without metastatic disease may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies that prevent or treat metastatic breast cancer.
How similar studies have performed: Other research has shown promising results in understanding the tumor microenvironment's role in cancer metastasis, suggesting that this approach could lead to significant advancements.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Oktay, Maja Hrzenjak — Albert Einstein College of Medicine
- Study coordinator: Oktay, Maja Hrzenjak
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.